Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Used BioTech Company For Sale by Owner - 600M OBO.

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon Jun 15, 2022 12:01pm

161 Views

Post# 34758303

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.

This is going to get really ugly until after September. 25 million shares worth of warrants to be exercised between August 16th and September 2022. This stock cannot handle 25 million in volume, especially when you look at the fact that for 2022 so far, there has only been around ~31 million shares traded on the tsx/tsxv ALL YEAR for this stock.

<< Previous

Bullboard Posts

Next >>

Canada-U.S. space collaboration to enhance orbital launch capabilities